Tradestie Institutional Equity Comparison Engine
AKAN vs CISS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
AKAN Overall Edge
AKAN Captures Institutional Edge (2โ1 Pillars ยท 3โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Akanda Corp. Common Shares (AKAN) driven by superior Momentum & Technical, Options & Structure while CISS counters with relative strength in Growth & Margin. Fundamentally, AKAN trades at N/M Forward P/E with -1254.5% operating margin (+21.9% YoY revenue) versus CISS at N/M Forward P/E and 24.6% operating margin (+249.0% YoY). In options structure, AKAN sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against CISS sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
AKAN N/M vs CISS N/M Fwd P/E
Growth & Margin Winner
CISS
Op Margin -1254.5% vs 24.6% ยท YoY +21.9% vs +249.0%
Momentum & Technical Winner
AKAN
1Y +358.3% vs -25.4% ยท 52W Pos 5% vs 20%
Options & Structure Winner
AKAN
BREAKDOWN (N/A IV) vs BREAKDOWN (N/A IV)
AKAN
NASDAQ
Akanda Corp. Common Shares
Medicinal Chemicals & Botanical Products
$4.23
+23.32% 1D
Market Cap
$12.2M
1M Return
+267.83%
1Y Return
+358.29%
Forward P/E
N/M
Unified AI Score
39.8 / 100
SELL
Tech 15.0
Fund 36.0
Flow 50.0
Mom 50.0
CISS
NASDAQ
C3is Inc. Common Stock
Deep Sea Foreign Transportation Of Freight
$1.23
+4.24% 1D
Market Cap
$991,199
1M Return
+135.23%
1Y Return
-25.45%
Forward P/E
N/M
Unified AI Score
33.6 / 100
SELL
Tech 5.0
Fund 29.0
Flow 50.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
AKAN +358.29%
CISS -25.45%
Spread: +383.74 pp (AKAN Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
AKAN TTM Op. Margin: -1254.5%
CISS TTM Op. Margin: 24.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AKAN vs CISS. Trailing 12-month operating profitability (AKAN -1254.5% vs CISS 24.6%) and valuation multiples (AKAN N/M vs CISS N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AKAN | CISS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $12.2M | $991,199 | Larger Scale | AKAN |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +21.9% | +249.0% | Higher Growth | CISS |
| Operating Margin (TTM) Profitability | -1254.5% | 24.6% | Higher Margin | CISS |
| Net Profit Margin Profitability | 0.0% | 27.4% | Higher Margin | CISS |
| Return on Equity (ROE) Capital Efficiency | -60.9% | 17.1% | Higher ROE | CISS |
| 52-Week Range Position Momentum | 5% ($0โ$79) | 20% ($0โ$6) | Stronger Trend | CISS |
| Beta / 30D Volatility Risk Regime | 4.82ฮฒ ยท 524% Vol | 11.91ฮฒ ยท 1054% Vol | Lower Realized Risk | AKAN |
| Unified Institutional Score Composite Signal | 39.8 / 100 (SELL) | 33.6 / 100 (SELL) | Higher Composite | AKAN |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full AKAN vs CISS Buy Guide
AKAN
BREAKDOWN
140d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
CISS
BREAKDOWN
64d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither AKAN nor CISS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.